Biggest News Aggregation in the World
📰 Minor Use News

Page 2 - Minor Use News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Minor Use. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Jaguar Health, Inc.: Canalevia-CA1, Jaguar Animal Health's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea in Dogs, Now Available from Chewy

Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN FRANCISCO, CA / ACCESSWIRE / May 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or
Kian Wendt Jaguar Health Inc Jaguar Animal Health Napo Pharmaceuticals Inc Jaguar Health Inc View Jaguar Health

Jaguar Health, Inc.: U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care

91.67% of respondents to a question asking how they see themselves using the product in the future indicated they plan on increasing use of Canalevia®-CA1 over timeCanalevia-CA1, Jaguar Health's FDA Conditionally
Kian Wendt Jaguar Health Inc Jaguar Health Inc View Drug Administration Napo Therapeutics Jaguar Animal Health Jaguar Animal Health

Jaguar Health, Inc.: Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea in Dogs

Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDAIn December 2022, FDA increased the maximum number of dogs that can be treated annually with a
Michael Guy Drug Administration Veterinary Cancer Society Napo Pharmaceuticals Inc Jaguar Animal Health Jaguar Health Inc View

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science